NCT01914692View on ClinicalTrials.gov

Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection

PHASE4CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Gastric Cancer After D2 Lymph Node Dissection
Interventions
DRUG

Somatostatin

Somatostatin is a kind of traditional medicines ,which is for the treatment of intestinal fistula，upper gastrointestinal hemorrhage.

All Listed Sponsors
lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT01914692 - Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection | Biotech Hunter | Biotech Hunter